PREVALENCE OF CERVICAL CANCER AMONG THE WOMEN’S ATTENDING THE TERTIARY CARE CENTER OF EASTERN PART OF BIHAR
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i11.48191Keywords:
Screening, Cancer cervix, Human papillomavirus, Pap smear, ProgramsAbstract
Objectives: The objective of this study was to study the prevalence of cervical cancer and its grade in the patients presenting to the gynecology outpatient department (OPD) of a tertiary care center.
Methods: This is a record based cross-section study which shows the percentage of women having pathological cervical lesions from the total number presenting to gynecology OPD of our tertiary hospital with specific symptoms with in a period of more than past 2 year.
Results: As the catchment area is of lower status general health which was low and routine regular check-up was not considered important by the patients. Poor knowledge about cancer cervix and lack of regular screening at primary center’s was the main constraint. The mean age of patient was 37±5.4 years and shows that maximum incidence that is reported is of negative for intraepithelial lesion for malignancy followed atypical squamous cells of undetermined significance and high-grade squamous intraepithelial lesion.
Discussion: The major limitation found in this study was lack of proper knowledge among patients, poor health-care facilities, and shortage of trained staffs. It is essential to upgrade the basic facilities of primary health-care centers and mass education to vulnerable age group and enhanced awareness on this issue will lead to early diagnosis and greater chance of screening leading to timely diagnosis and treatment.
Conclusion: Lack of awareness has led to underreporting and faulty health seeking behaviour has led to delayed diagnosis. Comprehensive approach and affordable extended package of health care under Ayushmann Bharat can be helpful in reducing the disease burden.
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. doi: 10.3322/caac.21660, PMID: 33538338
Available from: https://dhr.gov.in/health-technology-assessment-strategies-cervical-cancer-screening-india
Available from: https://www.nhp.gov.in/disease/reproductive-system/ female-gynaecological-diseases-/cervical-cancer [Last assessed on 2023 Mar 23].
Operational Guidelines on Prevention, Screening and Control of Common. Available from: https://main.mohfw.gov.in/sites/default/ files/Operational%20Guidelines%20on%20Prevention%2C%20 Screening%20and%20Control%20of%20Common%20NCDs_1.pdf [Last accessed on 2023 Oct 21].
Available from: https://www.who.int/news/item/17-11-2020-a-cervical-cancer-free-future-first-ever-global-commitment-to-eliminate-a-cancer [Last accessed on 2023 Mar 26].
Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 2020;383:1340-8. doi: 10.1056/NEJMoa1917338. PMID: 32997908
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health 2020;8:e191-203. doi: 10.1016/S2214-109X(19)30482-6 Erratum in: Lancet Glob Health 2022;10:e41. PMID: 31812369; PMCID: PMC7025157
Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ. Cancer in Africa 2018: The role of infections. Int J Cancer 2020;146:2089-103. doi: 10.1002/ijc.32538, PMID: 31254479
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020;395:591-603. doi: 10.1016/ S0140-6736(20)30157-4, PMID: 32007142; PMCID: PMC7043006
Hoskin P, Goh V, editors. Radiotherapy in Practice-imaging. Oxford: Oxford Academic Books; 2010. doi: 10.1093/ med/9780199231324.001.0001. Available from: Radiotherapy in Practice - Imaging | Oxford Academic (oup.com) [Last accessed on 2023 Jun 03].
Available from: https://main.icmr.nic.in/sites/default/files/reports/ Cervix%20Cancer.pdf [Last accessed on 2023 Oct 21].
Available from: https://rchiips.org/nfhs/factsheet_nfhs-5.shtml [Last assessed on 2023 Mar 23].
Dhillon PK, Hallowell BD, Agrawal S, Ghosh A, Yadav A, Van Dyne E, et al. Is India’s public health care system prepared for cervical cancer screening?: Evaluating facility readiness from the fourth round of the District Level Household and Facility Survey (DLHS-4). Prev Med 2020;138:106147. doi: 10.1016/j.ypmed.2020.106147, PMID: 32473272; PMCID: PMC7783584
Van Dyne EA, Hallowell BD, Saraiya M, Senkomago V, Patel SA, Agrawal S, et al. Establishing baseline cervical cancer screening coverage-India, 2015-2016. MMWR Morb Mortal Wkly Rep 2019;68:14-9. doi: 10.15585/mmwr.mm6801a4. PMID: 30629571
WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention: Use of mRNA Tests for Human Papillomavirus (HPV). Geneva: World Health Organization; 2021.
Ivanuš U, Jerman T, Oblak UG, Meglič L, Florjančič M, Fležar MS, et al. The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry. Lancet Reg Health Eur 2021;5:100101. doi: 10.1016/j. lanepe.2021.100101. PMID: 34557821; PMCID: PMC8454727
Published
How to Cite
Issue
Section
Copyright (c) 2023 dr binay kumar, Nidhi Prasad
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.